Kevin KWEI
Inventor
Stats
- 1 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 5 US Applications Filed
- 25 Total Citation Count
- Sep 6, 2022 Most Recent Filing
- Jun 14, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| ONYX THERAPEUTICS, INC. | 1
| 2014
|
| System Biosciences, LLC | 2
| 2013
|
Inventor Addresses
| Address | Duration |
|---|---|
| Mountain View, CA, US | Dec 19, 13 - Jul 27, 23 |
| Thousand Oaks, CA, US | Nov 12, 20 - Nov 12, 20 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
| C12M: | APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2023/0235,406 | 2023 | IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE | 0 |
| 2021/0238,691 | 2021 | IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBITOR RESPONSE | 0 |
| 10870889 | 2020 | Immunoglobulin expression levels as biomarker for proteasome inhibitor response | 0 |
| 2020/0354,793 | 2020 | Immunoglobulin Expression Levels as Biomarker for Proteasome Inhibitor Response | 0 |
| 10662479 | 2020 | Immunoglobulin expression levels as biomarker for proteasome inhibitor response | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.